Recently, nucleotide-binding oligomerization domain 2 NOD2 mutations were involved in the pathogenesis of sarcoidosis, as well as in Blau syndrome (BS) and early onset sarcoidosis (EOS) [4,5,6,7]. Here, NOD2 is linked to sarcoidosis.